Inspire Medical Systems, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference
Inspire Medical Systems (NYSE: INSP) announced that its management team will present at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026, at 1:30 p.m. Eastern Time.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Inspire Medical Systems (NYSE: INSP) announced that its management team will present at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026, at 1:30 p.m. Eastern Time. The presentation will be available via live webcast with a two-week replay on Inspire’s investor website.
Details
News Market Reaction – INSP
On Aug 26, the day this news came out, INSP closed 1.28% above the previous close. Argus tracked a trough of -8.5% from its starting point during tracking. Our momentum scanner recorded 2 alerts in the available session data.
Data tracked by StockTitan Argus for the Aug 26 session.
Key Figures
- Conference edition
- 21st annual
- Wells Fargo Healthcare Conference
- Presentation date
- September 9, 2026
- Scheduled conference presentation
- Presentation time
- 1:30 p.m. Eastern Time
- Scheduled presentation
- Replay availability
- two weeks
- Following the presentation
Historical Context
-
Mobia appointed a director who also served on Inspire's board.
-
Inspire reported Q2 results and raised 2026 revenue guidance.
-
Inspire appointed medical-device executive Michael H. Carrel to its board.
-
Director Casey M. Tansey announced retirement after more than 18 years.
-
Inspire corrected the scheduled date for its second-quarter results.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
obstructive sleep apnea medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
MINNEAPOLIS, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026.
Inspire is scheduled to present at 1:30 p.m. Eastern Time. The presentation will be accessible via a live webcast here.
A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media Contact
Louisa Smith
Principal, Gilmartin Group
IR@inspiresleep.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.